| 000 | 01833cam a2200313 i 4500 | ||
|---|---|---|---|
| 999 |
_c12552 _d12552 |
||
| 001 | 2300681 | ||
| 005 | 20210816140301.0 | ||
| 008 | 811103s1981 dcua b 101 0 eng | ||
| 010 | _a 80070561 | ||
| 020 | _a091733034X (pbk.) | ||
| 040 |
_aDLC _cDLC _dDLC _erda |
||
| 050 | 0 | 0 |
_aRS201.C64 _bC66 |
| 082 | 0 | 0 |
_a615.191 _222 _bC |
| 245 | 0 | 0 |
_aControlled - release pharmaceuticals / _cedited by John Urquhart. |
| 260 |
_aWashington, D.C. : _bAmerican Pharmaceutical Association, Academy of Pharmaceutical Sciences, Pharmacology and Toxicology Section, _cc1981. |
||
| 300 |
_axi, 145 pages. : _billustrations ; _c23 cm. |
||
| 336 |
_2rdacontent _atext |
||
| 337 |
_2rdamedia _aunmediated |
||
| 338 |
_2rdacarrier _avolume |
||
| 500 | _a"Based on a symposium sponsored by the APS Section on Pharmacology and Toxicology at the 27th national meeting of the Academy of Pharmaceutical Sciences, Kansas City, Missouri, November 1979."--T.p. verso. | ||
| 504 | _aIncludes bibliographical references and index. | ||
| 505 | 0 | _aIntroduction -- Performance requirements for controlled-release dosage forms : therapeutic and pharmacological perspectives / John Urquhart -- Clinical limitations of controlled-release dosage forms / L.F. Prescott -- Controlled-release dosage form design / Felix Theeuwes and William Bayne -- Pharmacokinetic requirements for controlled-release dosage forms / J.D. Rogers and K.C. Kwan -- The effect of the therapeutic regimen on patient compliance and the possible influence of controlled-release dosage forms / R.B. Haynes. | |
| 650 | 0 |
_aDrugs _xControlled release _xCongresses. |
|
| 700 | 1 |
_aUrquhart, John, _d1934- |
|
| 710 | 2 |
_aAcademy of Pharmaceutical Sciences. _bPharmacology and Toxicology Section. |
|
| 906 |
_a7 _bcbc _corignew _d2 _eopcn _f19 _gy-gencatlg |
||
| 942 |
_2ddc _cBK |
||